Reply: budesonide

Affiliations

Comment

William J Sandborn et al. Gastroenterology. 2013 Mar.

. 2013 Mar;144(3):e23-4.

doi: 10.1053/j.gastro.2013.01.051. Epub 2013 Jan 26.

No abstract available

Comment on

Once-daily budesonide MMX® extended-release tablets induce remission in patients with mild to moderate ulcerative colitis: results from the CORE I study.
Sandborn WJ, Travis S, Moro L, Jones R, Gautille T, Bagin R, Huang M, Yeung P, Ballard ED 2nd. Sandborn WJ, et al. Gastroenterology. 2012 Nov;143(5):1218-1226.e2. doi: 10.1053/j.gastro.2012.08.003. Epub 2012 Aug 11. Gastroenterology. 2012. PMID: 22892337 Clinical Trial.
Budesonide MMX and mesalamine to induce remission in patients with ulcerative colitis.
Criscuoli V, Sinagra E, Cottone M. Criscuoli V, et al. Gastroenterology. 2013 Mar;144(3):e23. doi: 10.1053/j.gastro.2012.12.032. Epub 2013 Jan 25. Gastroenterology. 2013. PMID: 23352592 No abstract available.